top of page
Technology

Immune Topology
HLA-typing is essential for determining each patient's unique HLA type, which is critical for the immune system's ability to recognize and target cancer cells effectively.
Tumor Analysis
Our advanced RNA-sequencing of tumor samples enables the identification of highly expressed tumor antigens. This analysis also detects downregulated HLA alleles, a crucial factor in designing effective cancer vaccines and a unique advancement of our technology.
Vaccine Design
Our vaccine design process focuses on identifying putative peptide sequences that contain optimized amounts of highly immunogenic sections, known as epitopes. This ensures that our vaccines are tailored to elicit a strong and targeted immune response.
bottom of page